Gregory Hughes

4.1k total citations · 1 hit paper
42 papers, 2.6k citations indexed

About

Gregory Hughes is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gregory Hughes has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gregory Hughes's work include Synthetic Organic Chemistry Methods (7 papers), Asymmetric Synthesis and Catalysis (5 papers) and Chemical Synthesis and Analysis (4 papers). Gregory Hughes is often cited by papers focused on Synthetic Organic Chemistry Methods (7 papers), Asymmetric Synthesis and Catalysis (5 papers) and Chemical Synthesis and Analysis (4 papers). Gregory Hughes collaborates with scholars based in United States, Canada and United Kingdom. Gregory Hughes's co-authors include Jacob M. Janey, Christopher K. Savile, Fred J. Fleitz, Jeffrey C. Moore, William R. Jarvis, Anke Krebber, Paul N. Devine, Gjalt W. Huisman, Emily C. Mundorff and Stephen L. Buchwald and has published in prestigious journals such as Science, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Gregory Hughes

40 papers receiving 2.5k citations

Hit Papers

Biocatalytic Asymmetric Synthesis of Chiral Amines from K... 2010 2026 2015 2020 2010 400 800 1.2k

Peers

Gregory Hughes
Gregory Hughes
Citations per year, relative to Gregory Hughes Gregory Hughes (= 1×) peers Ryszard Ostaszewski

Countries citing papers authored by Gregory Hughes

Since Specialization
Citations

This map shows the geographic impact of Gregory Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Hughes more than expected).

Fields of papers citing papers by Gregory Hughes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Hughes. The network helps show where Gregory Hughes may publish in the future.

Co-authorship network of co-authors of Gregory Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Hughes. A scholar is included among the top collaborators of Gregory Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Hughes. Gregory Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Gregory, et al.. (2022). Targeting mitochondrial dysfunction with elamipretide. Heart Failure Reviews. 27(5). 1925–1932. 15 indexed citations
2.
Reger, Mark A., Traci H. Abraham, Sara J. Landes, et al.. (2022). Development of the Veterans Crisis Line Caring Letters Suicide Prevention Intervention. Health Services Research. 57(S1). 42–52. 10 indexed citations
3.
Katz, Ira R., et al.. (2020). Suicide mortality and related behavior following calls to the Veterans Crisis Line by Veterans Health Administration patients. Suicide and Life-Threatening Behavior. 51(3). 596–605. 14 indexed citations
4.
Hughes, Gregory, et al.. (2019). Andexanet Alfa (Andexxa®) for the Reversal of Direct Oral Anticoagulants.. PubMed. 44(9). 530–549. 12 indexed citations
5.
Hughes, Gregory, et al.. (2018). Design and Delivery of Clinical Pharmacokinetics in Colleges and Schools of Pharmacy. American Journal of Pharmaceutical Education. 82(9). 6430–6430. 5 indexed citations
6.
Tran, Tran H., et al.. (2015). Overview of Current and Alternative Therapies for Idiopathic Membranous Nephropathy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(4). 396–411. 21 indexed citations
7.
Hughes, Gregory, et al.. (2014). Modification of a Pharmacokinetics Course Design to Improve Student Performance. American Journal of Pharmaceutical Education. 78(5). 93–93. 8 indexed citations
8.
Hughes, Gregory & Olga Hilas. (2014). Edoxaban: an investigational factor xa inhibitor.. PubMed. 39(10). 686–715. 4 indexed citations
9.
Hughes, Gregory, et al.. (2014). Medical Resident Choices of Electronic Drug Information Resources. Journal of Pharmacy Practice. 28(3). 280–283. 7 indexed citations
10.
Hughes, Gregory, et al.. (2011). The Impact of Pharmacist Interventions on the Inappropriate Use of Acid-Suppression Therapy. The Consultant Pharmacist. 26(7). 485–490. 14 indexed citations
11.
Hughes, Gregory, et al.. (2011). Effect of Acetaminophen on International Normalized Ratio in Patients Receiving Warfarin Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(6). 591–597. 18 indexed citations
12.
Truppo, Matthew D. & Gregory Hughes. (2011). Development of an Improved Immobilized CAL-B for the Enzymatic Resolution of a Key Intermediate to Odanacatib. Organic Process Research & Development. 15(5). 1033–1035. 38 indexed citations
13.
Savile, Christopher K., Jacob M. Janey, Emily C. Mundorff, et al.. (2010). Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture. Science. 329(5989). 305–309. 1299 indexed citations breakdown →
14.
Taylor, Mark, et al.. (2007). The use of animation in higher education teaching to support students with dyslexia. Education + Training. 49(1). 25–35. 20 indexed citations
15.
Hughes, Gregory & Peter Robinson. (2007). Photonote evaluation. 99–106. 7 indexed citations
17.
Black, W. Cameron, Christine Brideau, Chi-Chung Chan, et al.. (2003). 3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 13(6). 1195–1198. 29 indexed citations
18.
Black, W. Cameron, Christine Brideau, Chi‐Chung Chan, et al.. (1999). 2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors. Journal of Medicinal Chemistry. 42(7). 1274–1281. 45 indexed citations
19.
Jacobson, W., et al.. (1988). Tracheal aspirates from neonates during endotracheal intubation: Detection of surfactant by polarized light microscopy. The Journal of Pediatrics. 113(2). 368–372. 11 indexed citations
20.
Moore, Harold W. & Gregory Hughes. (1982). Cyanoketenes. Cycloadditions of chlorocyanoketene to α,β-unsaturated imines. Tetrahedron Letters. 23(39). 4003–4006. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026